| Name | Title | Contact Details |
|---|---|---|
Jesse Bishop |
Vice President, Regulatory | Profile |
Bradley Ottinger |
General Counsel and Chief Compliance Officer | Profile |
Gregory Freitag |
General Counsel | Profile |
Marc Began |
Executive Vice President and General Counsel | Profile |
Revance Therapeutics is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, including muscle movement disorders and pain. The company`s lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines, cervical dystonia and plantar fasciitis with the potential to be the first long-acting neuromodulator. Revance has developed a proprietary, stabilizing excipient peptide technology designed to create novel, differentiated therapies. The company has a comprehensive pipeline based upon its peptide technology, including injectable and topical formulations of daxibotulinumtoxinA.
Third Wave Technologies, Inc. is a Madison, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
AmbioPharm is a Beech Island, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2019, Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Totus is based in Cambridge, Massachusetts.
World Views Spatial Technologi is a Barrington, RI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.